Talis Biomedical CorporationTT

Talis Biomedical Corporation

1,76USDD
−0,14−7,37%
Última atualização em 18 de fev., 20:57 GMT
USD
Sem negociaçõesPré-mercado
Veja nos super gráficos

Fundamentos de TLIS

Demonstrações financeiras do Talis Biomedical Corporation, incluindo receita, despesas e lucro

A receita total de TLIS para o último trimestre é 0.00 USD, e é 100.00% menor comparada ao trimestre anterior. Lucro líquido de Q2 24 é -8.85 M USD.

Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪‪−27,00 M‬‬
‪‪−18,00 M‬‬
‪‪−9,00 M‬‬
‪0,00‬
‪‪9,00 M‬‬
Receita Total
Lucro Bruto
Resultado Operacional
Receita antes de impostos
Lucro Líquido
Moeda: USD
Q1 '19
Маr 2019
Q2 '19
Jun 2019
Q3 '19
Set 2019
Q4 '19
Dez 2019
Q1 '20
Маr 2020
Q2 '20
Jun 2020
Q3 '20
Set 2020
Q4 '20
Dez 2020
Q1 '21
Маr 2021
Q2 '21
Jun 2021
Q3 '21
Set 2021
Q4 '21
Dez 2021
Q1 '22
Маr 2022
Q2 '22
Jun 2022
Q3 '22
Set 2022
Q4 '22
Dez 2022
Q1 '23
Маr 2023
Q2 '23
Jun 2023
Q3 '23
Set 2023
Q4 '23
Dez 2023
Q1 '24
Маr 2024
Q2 '24
Jun 2024
TTM
Receita TotalCrescimento Ano a Ano
‪‪730,00 K‬‬
‪‪107,00 K‬‬
‪‪137,00 K‬‬
−94,08%
‪‪48,00 K‬‬
−90,44%
‪‪76,00 K‬‬
−89,59%
‪‪151,00 K‬‬
+41,12%
‪‪73,00 K‬‬
−46,72%
‪0,00‬
−100,00%
‪‪300,00 K‬‬
‪‪−6,11 M‬‬
‪‪−6,71 M‬‬
‪‪−979,00 K‬‬
‪‪−2,85 M‬‬
‪‪−664,00 K‬‬
‪‪−219,00 K‬‬
‪‪−268,00 K‬‬
‪‪−84,00 K‬‬
‪‪−1,24 M‬‬
Lucro BrutoCrescimento Ano a Ano
‪‪−5,38 M‬‬
−650,84%
‪‪−6,61 M‬‬
−583,04%
‪‪−842,00 K‬‬
+57,47%
‪‪−2,80 M‬‬
−17,78%
‪‪−588,00 K‬‬
+89,06%
‪‪−68,00 K‬‬
+98,97%
‪‪−195,00 K‬‬
+76,84%
‪‪−84,00 K‬‬
+97,00%
‪‪−935,00 K‬‬
‪‪−21,48 M‬‬
‪‪−18,07 M‬‬
‪‪−19,24 M‬‬
‪‪−14,12 M‬‬
‪‪−16,45 M‬‬
‪‪−14,43 M‬‬
‪‪−8,95 M‬‬
‪‪−8,49 M‬‬
‪‪−48,32 M‬‬
Resultado OperacionalCrescimento Ano a Ano
‪‪−26,85 M‬‬
+30,49%
‪‪−24,67 M‬‬
+16,03%
‪‪−20,08 M‬‬
+40,67%
‪‪−16,92 M‬‬
+38,10%
‪‪−17,04 M‬‬
+36,56%
‪‪−14,50 M‬‬
+41,22%
‪‪−9,15 M‬‬
+54,45%
‪‪−8,58 M‬‬
+49,31%
‪‪−49,26 M‬‬
‪‪831,00 K‬‬
‪‪−2,26 M‬‬
‪‪2,25 M‬‬
‪‪1,89 M‬‬
‪‪1,35 M‬‬
‪‪1,04 M‬‬
‪‪−3,89 M‬‬
‪‪−271,00 K‬‬
‪‪−1,77 M‬‬
Receita antes de impostosCrescimento Ano a Ano
‪‪−26,02 M‬‬
+32,27%
‪‪−26,93 M‬‬
+6,02%
‪‪−17,83 M‬‬
+46,05%
‪‪−15,03 M‬‬
+44,34%
‪‪−15,68 M‬‬
+39,73%
‪‪−13,46 M‬‬
+50,02%
‪‪−13,04 M‬‬
+26,90%
‪‪−8,85 M‬‬
+41,14%
‪‪−51,03 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−26,02 M‬‬
‪‪−26,93 M‬‬
‪‪−17,83 M‬‬
‪‪−15,03 M‬‬
‪‪−15,68 M‬‬
‪‪−13,46 M‬‬
‪‪−13,04 M‬‬
‪‪−8,85 M‬‬
‪‪−51,03 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
Lucro LíquidoCrescimento Ano a Ano
‪‪−26,02 M‬‬
+32,27%
‪‪−26,93 M‬‬
+6,02%
‪‪−17,83 M‬‬
+46,05%
‪‪−15,03 M‬‬
+44,34%
‪‪−15,68 M‬‬
+39,73%
‪‪−13,46 M‬‬
+50,02%
‪‪−13,04 M‬‬
+26,90%
‪‪−8,85 M‬‬
+41,14%
‪‪−51,03 M‬‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪0,00‬
‪‪−26,02 M‬‬
‪‪−26,93 M‬‬
‪‪−17,83 M‬‬
‪‪−15,03 M‬‬
‪‪−15,68 M‬‬
‪‪−13,46 M‬‬
‪‪−13,04 M‬‬
‪‪−8,85 M‬‬
‪‪−51,03 M‬‬
‪−14,65‬
−41,90%
‪−15,07‬
−97,36%
‪−9,97‬
+46,75%
‪−8,27‬
+45,65%
‪−8,62‬
+41,15%
‪−7,39‬
+50,99%
‪−7,15‬
+28,27%
‪−4,86‬
+41,31%
‪−28,02‬
‪−14,65‬
−41,90%
‪−15,07‬
−97,36%
‪−9,97‬
+46,75%
‪−8,27‬
+45,65%
‪−8,62‬
+41,15%
‪−7,39‬
+50,99%
‪−7,15‬
+28,27%
‪−4,86‬
+41,31%
‪−28,02‬
‪‪1,78 M‬‬
‪‪1,79 M‬‬
‪‪1,79 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,78 M‬‬
‪‪1,79 M‬‬
‪‪1,79 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
‪‪1,82 M‬‬
EBITDACrescimento Ano a Ano
‪‪−21,98 M‬‬
+42,03%
‪‪−20,29 M‬‬
+28,58%
‪‪−19,12 M‬‬
+42,18%
‪‪−14,08 M‬‬
+45,35%
‪‪−16,38 M‬‬
+25,50%
‪‪−14,29 M‬‬
+29,58%
‪‪−8,88 M‬‬
+53,53%
‪‪−8,49 M‬‬
+39,68%
‪‪−48,04 M‬‬
EBITCrescimento Ano a Ano
‪‪−26,85 M‬‬
+30,49%
‪‪−24,67 M‬‬
+16,03%
‪‪−20,08 M‬‬
+40,67%
‪‪−16,92 M‬‬
+38,10%
‪‪−17,04 M‬‬
+36,56%
‪‪−14,50 M‬‬
+41,22%
‪‪−9,15 M‬‬
+54,45%
‪‪−8,58 M‬‬
+49,31%
‪‪−49,26 M‬‬
‪‪−27,58 M‬‬
‪‪−24,78 M‬‬
‪‪−20,21 M‬‬
‪‪−16,97 M‬‬
‪‪−17,11 M‬‬
‪‪−14,65 M‬‬
‪‪−9,22 M‬‬
‪‪−8,58 M‬‬
‪‪−49,56 M‬‬